期刊文献+

草酸铂加CF/5-FU48小时持续静脉滴注双周疗法治疗晚期胃癌83例疗效分析 被引量:6

Clinical study of the curative effect of oxaliplatin plus CF/5-FU in advanced gastric cancerby biweekly therapy of 48-hour continuous intravenous infusion
下载PDF
导出
摘要 目的:观察草酸铂(L-OHP)与CF/5-FU48小时持续静脉滴注双周疗法治疗晚期胃癌疗效及不良反应。方法:经病理证实的83例晚期胃癌患者随机分为治疗组和对照组。治疗方案:治疗组用L-OHP加CF/5-FU;对照组用VP16加CF/5-FU,两组均2周为1周期。结果:经过2个周期化疗,治疗组有效率(CR+PR)57.5%比对照组有效率34.9%高,两组比较差异有统计学意义(#2=4.2702,P=0.0388)。治疗中无疾病进展及治疗相关死亡,胃肠道反应及骨髓抑制均为轻中度,无显著性差异。神经毒性治疗组明显低于对照组,两组差异有统计学意义(P<0.01)。结论:L-OHP加CF/5-FU48小时持续静脉滴注双周疗法治疗晚期胃癌疗效高,不良反应轻,有希望成为最有效的治疗方案。 Objective:To observe the anti-tumor effect and safety of oxaliplatin combined with CF/5-FU in the treatment of advanced gastric cancer by biweekly therapy of 48-bour continuous intravenous infusion.Methods:83 patients with advanced gastric cancer were randomly divided into treatment group and control group. Treatment group was treated with oxaliplatin plus CF/5-FU added into the chemotherapy pump by 48-hour continuous intravenous infusion,while Control group was treated with VP16 plus CF/5-FU in the same method as treatment group,a cycle was two weeks.AN enrolled patients received two cycles of treatment.Results:The effective rate was 57.5% in the treatment group and 34.9% in the control group,with a significant difference between them (x^2=4.2902,P=0.0388),There was no significant difference in bone marrow suppression,nausea and vomiting between two groups.The rate of peripheral neurilemmitis response had significant difference between two groups (P〈0.001). Conclusion:Oxaliplatin plus CF/5-FU by biweekly therapy of 48-hour continuous infusion is very effective for the treatment of advanced gastric cancer with mild toxicity, which can be practiced safety.
出处 《现代医药卫生》 2006年第10期1436-1437,共2页 Journal of Modern Medicine & Health
关键词 L-OHP CF/5-FU 晚期胃癌 持续静脉滴注 双周疗法 草酸铂 Oxaliplafin CF/5-FU Advanced gastric cancer Intravenous infusion Biweek therapy
  • 相关文献

参考文献6

  • 1Wilke H,Preusser P,Fink U,et al.New developments in the treatment of gastric carcinoma[J].Semin Oncol,1990,17(1):61.
  • 2Tsai JY,Safran H.Ststus of treatment for advanced gastric carcinoma[J].Curr Oncol Rep,2003,5(3):210.
  • 3de Gramont A,Louvet C,Andre T,et al.A review of GERCOD trials of bimonthly leucovorin plus 5-fluorouracil 48-h continuous infusion in advanced colorectal cancer:evolution of a regimen[J].Eur J Cancer,1998,34(5):619.
  • 4金懋林,陈强,程凤歧,陈伟,陈黎,潘良熹,杨宇飞.奥沙利铂联合亚叶酸钙和5-氟尿嘧啶治疗晚期胃癌的研究[J].中华肿瘤杂志,2003,25(2):172-174. 被引量:404
  • 5Al-Batran SE,Atmaca A,Hegewisch-Becker S,et al.Phase Ⅱ trial of biweekly infusional fluorouracil,folinic acid,and oxaliplatin in patients with advanced gastric cancer[J].J Clin Oncol,2004,22(4):658.
  • 6Kim DY,Kim JH,Lee SH.Phase II study of oxaliplatin,5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer[J].Ann Oncol.2003,14(3):383.

二级参考文献6

  • 1De Gramont A, Krulik M, Cady J, et al. High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer.Eur J Cancer Clin Oncol, 1988, 24:1499-1503.
  • 2Ajani JA. Current status of therapy for advanced gastric carcinoma.Oncology, 1998, 12:99-102.
  • 3Raymond E, Charley SG, Taamma A, et al. Oxaliplatin: a review of preclinical and clinical studies. Ann Oncol, 1998, 9:1053-1071.
  • 4De Gramont A, Figer A, Seymonr M, et al. Leucovorin and fluorouracil with or without oxaliplatin as frist-line treatment in advanced colorectal cancer. J Clin Oncol, 2000,18:2938-2947.
  • 5De Gramont A, Bosset JF, Milan C, et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly highdose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer : a French intergroup study. J Clin Oncol,1997, 15:808-815.
  • 6金懋林.胃癌化学治疗的发展与运用[J].中国肿瘤临床,2000,27(10):792-798. 被引量:150

共引文献403

同被引文献39

引证文献6

二级引证文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部